The Valley Desk

ArticleBioanalysisPublished

2022 White Paper on Recent Issues in Bioanalysis: FDA Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, LNP & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolongation Effect, ADA Affinity, Risk-based Approaches, NGS, qPCR, ddPCR Assays (Part 3 - Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Immunogenicity & Risk Assessment of Biotherapeutics and Novel Modalities; NAb Assays Integrated Approach)

14 of 69 authors shown in byline order.

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK. Affiliation source

Publication record

Type
Article
Venue
Bioanalysis
Published
Subject terms
Biological Assay; Technology; Prescription Drugs; Cell- and Tissue-Based Therapy; Biomarkers; Gene therapy; Vaccine; Immunogenicity; Cell therapy; Bioanalysis; Wrib
PubMed ID
37526071
Added to directory
Source checked

Report a correction or request removal